Texas Senate · 89th Legislature, Regular Session
Official title: Relating to required reports of certain vaccine-related or drug-related adverse events.
Members who authored, joint-authored, or co-sponsored this bill.
SourceLegiScan (CC BY 4.0)89R
Senate Bill 269 adds Section 161.0103 and Section 431.1145 to the Health and Safety Code, each requiring a physician to report certain "serious adverse events," which the bill defines as events that result in death, are considered life-threatening, result in inpatient hospitalization or a longer hospital stay, result in persistent or significant incapacity or substantial disruption of normal life functions, result in a congenital anomaly or birth defect, or result in a medically important condition that may require medical or surgical intervention to prevent those outcomes. The requirements apply only to a vaccine or drug that is experimental or investigational or that the United States Food and Drug Administration has authorized or approved for emergency use, and they do not apply to a vaccine or drug administered or used as part of a clinical trial. A physician shall report a vaccine-related event to the federal Vaccine Adverse Event Reporting System and a drug-related event to the Food and Drug Administration through the MedWatch reporting program when the physician diagnoses the related condition, knows the patient received the vaccine or drug, and the patient suffers the event before the first anniversary of the vaccination or administration. An initial violation is subject to non-disciplinary corrective action by the Texas Medical Board and each subsequent violation to disciplinary action; the board may not consider a violation after the third anniversary of its date but shall retain each violation in the physician's permanent record. The executive commissioner shall adopt rules to implement the Act, which takes effect September 1, 2025.
Read the full text below for the definitive meaning.
The Legislative Budget Board’s fiscal note projects no significant fiscal impact. Read the note
Each version links to the authoritative document on capitol.texas.gov.
S.B. No. 269 AN ACT relating to required reports of certain vaccine-related or drug-related adverse events. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Subchapter A, Chapter 161, Health and Safety Code, is amended by adding Section 161.0103 to read as follows: Sec. 161.0103. REQUIRED REPORT OF CERTAIN VACCINE-RELATED ADVERSE EVENTS. (a) In this section, "serious adverse event" means an event that:
Statewide figures for the subjects tagged on this bill, to explore on the Data map. They describe Texas — not this bill or its effects.
SourceU.S. Census Bureau (ACS) & CDC PLACESstatewide Data layer
Each subject links to other 89R bills tagged the same way.
(1) results in death; (2) is considered life-threatening; (3) results in inpatient hospitalization or an extension of the duration of an existing hospitalization; (4) results in a persistent or significant incapacity or substantial disruption of an individual's ability to perform normal life functions; (5) results in a congenital anomaly or birth defect; or (6) results in a medically important condition that, based on the physician's reasonable medical judgment, may require medical or surgical intervention to prevent an outcome described by Subdivisions (1) through (5). (b) This section applies only to a vaccine that is: (1) experimental or investigational; or (2) authorized or approved for emergency use by the United States Food and Drug Administration. (c) Notwithstanding Subsection (b), this section does not apply to a vaccine administered as part of a clinical trial. (d) Notwithstanding any other law, a physician shall report to the federal Vaccine Adverse Event Reporting System any serious adverse event the physician's patient suffers if: (1) the physician: (A) diagnoses the patient with a condition related to the serious adverse event; and (B) knows the patient received a vaccination to which this section applies; and (2) the patient suffers the serious adverse event before the first anniversary of the date the patient was vaccinated. (e) A physician who violates this section is subject to: (1) for an initial violation, non-disciplinary corrective action by the Texas Medical Board; and (2) for each subsequent violation, disciplinary action by the Texas Medical Board as if the physician violated Subtitle B, Title 3, Occupations Code. (f) For purposes of non-disciplinary corrective action or disciplinary action imposed under Subsection (e), the Texas Medical Board may not consider a violation of this section after the third anniversary of the date of the violation. The Texas Medical Board shall retain information on each violation of this section in the physician's permanent record. (g) The executive commissioner shall adopt rules necessary to implement this section. SECTION 2. Subchapter E, Chapter 431, Health and Safety Code, is amended by adding Section 431.1145 to read as follows: Sec. 431.1145. REQUIRED REPORT OF CERTAIN DRUG-RELATED ADVERSE EVENTS. (a) In this section, "serious adverse event" means an event that: (1) results in death; (2) is considered life-threatening; (3) results in inpatient hospitalization or an extension of the duration of an existing hospitalization; (4) results in a persistent or significant incapacity or substantial disruption of an individual's ability to perform normal life functions; (5) results in a congenital anomaly or birth defect; or (6) results in a medically important medical condition that, based on the physician's reasonable medical judgment, may require medical or surgical intervention to prevent an outcome described by Subdivisions (1) through (5). (b) This section applies only to a drug that is: (1) experimental or investigational; or (2) authorized or approved for emergency use by the United States Food and Drug Administration. (c) Notwithstanding Subsection (b), this section does not apply to a drug that is administered or used as part of a clinical trial. (d) Notwithstanding any other law, a physician shall report to the United States Food and Drug Administration through the MedWatch reporting program any serious adverse event the physician's patient suffers if: (1) the physician: (A) diagnoses the patient with a condition related to the serious adverse event; and (B) knows the patient was administered or used a drug to which this section applies; and (2) the patient suffers the serious adverse event before the first anniversary of the date the patient was administered or used the drug. (e) A physician who violates this section is subject to: (1) for an initial violation, non-disciplinary corrective action by the Texas Medical Board; and (2) for each subsequent violation, disciplinary action by the Texas Medical Board as if the physician violated Subtitle B, Title 3, Occupations Code. (f) For purposes of non-disciplinary corrective action or disciplinary action imposed under Subsection (e), the Texas Medical Board may not consider a violation of this section after the third anniversary of the date of the violation. The Texas Medical Board shall retain information on each violation of this section in the physician's permanent record. (g) The executive commissioner shall adopt rules necessary to implement this section. SECTION 3. As soon as practicable after the effective date of this Act, the executive commissioner of the Health and Human Services Commission shall adopt rules necessary to implement the changes in law made by this Act. SECTION 4. This Act takes effect September 1, 2025. ______________________________ ______________________________ President of the Senate Speaker of the House I hereby certify that S.B. No. 269 passed the Senate on April 24, 2025, by the following vote: Yeas 31, Nays 0; and that the Senate concurred in House amendment on May 26, 2025, by the following vote: Yeas 31, Nays 0. ______________________________ Secretary of the Senate I hereby certify that S.B. No. 269 passed the House, with amendment, on May 22, 2025, by the following vote: Yeas 104, Nays 37, three present not voting. ______________________________ Chief Clerk of the House Approved: ______________________________ Date ______________________________ Governor
SourceTexas Legislative Council (capitol.texas.gov)official bill text (capitol.texas.gov)
SourceLegiScan (CC BY 4.0)subject tags
SourceTexas Legislative Council (capitol.texas.gov)89R
Recorded as a group vote — the source has the totals above but no individual member breakdown.
Recorded as a group vote — the source has the totals above but no individual member breakdown.
Recorded as a group vote — the source has the totals above but no individual member breakdown.
SourceLegiScan (CC BY 4.0)89R
SourceLegiScan (CC BY 4.0)official fiscal notes & analyses (TLC)
Perch never collects comments itself — it points you to the Legislature's own hearing schedule and official public-comment channels (ADR-0007).
Official hearings & comment (capitol.texas.gov) →SourceLegiScan (CC BY 4.0)hearing schedule